Cyclophosphamide-sensitive T lymphocytes suppress the in vivo generation of antigen-specific cytotoxic T lymphocytes.
about
Improved systemic delivery of oncolytic reovirus to established tumors using preconditioning with cyclophosphamide-mediated Treg modulation and interleukin-2Induction and modification of anti-TNP reaginic and IgG antibody responses by reactive trinitrophenyl derivativesPhenotype, functions and fate of adoptively transferred tumor draining lymphocytes activated ex vivo in mice with an aggressive weakly immunogenic mammary carcinomaCyclophosphamide enhances immunity by modulating the balance of dendritic cell subsets in lymphoid organs.Induction of suppressor T cells in delayed-type hypersensitivity to Mycobacterium bovis BCG in low-responder miceTumor-enhancing suppressor activator T cells in spleens and thymuses of tumor immune miceInduction of enhanced resistance against encephalomyocarditis virus infection of mice by nonviable Mycobacterium tuberculosis: mechanisms of protection.Selective effects of cyclophosphamide therapy on activation, proliferation, and differentiation of human B cells.GM-CSF gene-modifed cancer cell immunotherapies: of mice and men.Stimulation of anti-tumor immunity by photodynamic therapyImmunological effects of low-dose cyclophosphamide in cancer patients treated with oncolytic adenovirus.Autoimmune vasculitis resulting from in vitro immunization of lymphocytes to smooth muscleIn situ immune autoradiographic identification of cells in heart tissues of mice with coxsackievirus B3-induced myocarditis.In vivo detection and partial characterization of effector and suppressor cell populations in spleens of mice with large metastatic fibrosarcomas.The effect of adjuvant cyclophosphamide or tamoxifen on the numbers of lymphocytes bearing T cell or NK cell markers"Sneaking through": a T-cell-dependent phenomenon.Combination approaches to potentiate immune response after photodynamic therapy for cancer.Differential cyclophosphamide sensitivity of precursor cells in allogeneic and H-2 restricted cytotoxic responses.Regulation of specific cell-mediated cytotoxic response against SV40-induced tumor associated antigens by depletion of suppressor T cells with cyclophosphamide in mice.Induction and mode of action of suppressor cells generated against human gamma globulin. II. Effects of colchicine.Cyclophosphamide eliminates suppressor T cells in age-associated central regulation of delayed hypersensitivity in mice.Regression and inhibition of sarcoma growth by interference with a radiosensitive T-cell population.Temperature-sensitive mutant of coxsackievirus B3 establishes resistance in neonatal mice that protects them during adolescence against coxsackievirus B3-induced myocarditis.Enhancement of delayed hypersensitivity reaction with varieties of anti-cancer drugs. A common biological phenomenon.Cyclophosphamide-facilitated adoptive immunotherapy of an established tumor depends on elimination of tumor-induced suppressor T cellsSuccessful immunotherapy of natural killer-resistant established pulmonary melanoma metastases by the intravenous adoptive transfer of syngeneic lymphocytes activated in vitro by interleukin 2.Antiidiotypic immunity in interstitial nephritis. II. Rats developing anti-tubular basement membrane disease fail to make an antiidiotypic regulatory response: the modulatory role of an RT7.1+, OX8- suppressor T cell mechanism.Sensitization of B16 tumor cells with a CXCR4 antagonist increases the efficacy of immunotherapy for established lung metastases.Dexamethasone co-medication in cancer patients undergoing chemotherapy causes substantial immunomodulatory effects with implications for chemo-immunotherapy strategies.Rescue of anti-influenza A virus cytotoxic T-lymphocyte responses in chemotherapy-suppressed miceImmunosuppression with cyclophosphamide favors reinfection with recombinant Toxoplasma gondii strains.Correlation between in vivo and in vitro studies of modulation of resistance to experimental Candida albicans infection by cyclophosphamide in miceApoptosis as a mechanism of T-regulatory cell homeostasis and suppression.Pharmacologic and chemical adjuvants in tumor virotherapy.Cornea: Window to Ocular Immunology.Autophagy inhibition in cancer therapy: metabolic considerations for antitumor immunity.Immunotherapy of HPV infection-caused genital warts using low dose cyclophosphamide.Down-regulation of cytotoxic T lymphocyte generation by two distinct suppressor-cell systems.T-cell tolerance in transgenic mice expressing major histocompatibility class I molecules in defined tissues.The effect of cyclophosphamide on the immune system: implications for clinical cancer therapy.
P2860
Q24612603-7B5538C3-1A70-48C3-9FFE-6339DADC4A50Q28324536-952D368A-C1E1-4A71-9A04-F8084AA7D2FAQ33738279-E03E4F0D-0C27-49CD-81C2-E1140AA2067CQ33896713-5610C26F-9693-4AEA-A2AC-742AA118A033Q33902397-49F1FB54-A7D1-48A4-8838-EB0043549E86Q34038870-83A27D16-81F0-4B9B-B570-54EBCF774E33Q34462481-36797CAB-36B9-4EA4-9415-43E08DF624F5Q34566881-3E49104D-B66B-4C76-A8F5-EA3ED1D7D2A9Q34591128-C3A4C9B1-4F42-457D-9BBF-50BE1AC52190Q34697795-EF75483F-C96F-4CDA-A85C-6B310AC1F1ADQ35238258-90246894-125B-432F-9938-8D267EFEBBEFQ35835377-1FABD5AB-518F-4692-8FCD-300153C2169DQ35856321-BE9AE571-FA05-4F08-BEBF-B5F21BF41BD3Q35992368-4C5F7D84-47B5-41E7-8252-A9CA43BE7B08Q36027452-B646AB3C-9943-4B81-AB41-A69E1C960B38Q36045731-065AC5BC-1C60-41EE-99A0-BBC7F5D60EFBQ36253709-04D0D7DB-77CB-4674-946F-904C0EB5714BQ36341051-E91F0F84-1153-4E15-B978-BE147DF48517Q36341321-7FA3799F-FF76-4B60-8872-36D182661CD7Q36341441-C9822A4E-6736-4C8E-8408-2829F4CA7F1BQ36341471-7BCFE7E5-ED23-407A-B189-F070C0EEB56FQ36341857-5EF583AF-99A1-4487-8D2D-3632A216C5D5Q36344775-15863EE8-5365-4C8B-A38E-7C0A04A102FEQ36345351-8C78E5CD-11D6-4E56-9A35-D9192BF89A1AQ36346300-D5C24559-DA60-4DDB-ACCB-33D4C0283E28Q36348452-3703A03A-FEEB-4138-BB40-8C4D4DFF1934Q36348613-5B0924EE-2F26-41D1-8EC4-50BE631C448EQ36432030-E7F28548-569C-47D8-90B2-B8EA8F555C4CQ36821113-DB24E324-789D-4CDE-A5A8-8E334CAB70F4Q36892330-B00D9186-4623-475A-8D8D-0AF9B078ADB2Q36899227-65C22EA6-5C56-4A8C-BABD-C119D796446CQ37110457-8306D1AC-26C8-4F1C-97C7-D0B0954D930CQ37270469-B2D27232-5C56-46FC-A004-B8BB6B73CE75Q37492540-892C15AA-6A82-4F0F-8619-307CDC88CA0BQ37905546-FC216FF1-AD65-4AC0-8348-8AE1D90659A3Q38034270-F03B3BC7-57EB-4CF0-9CC3-89C74B56F7FEQ38211240-8A3A3257-AE33-4647-B4CF-16E848E1437FQ38518755-FB61F169-B70B-4C63-9764-9AF7BDB8A6C6Q38606069-C3B9E6E9-B726-42DB-B145-C676EA0B31C5Q38959130-E5E88309-DD09-4C9A-B63F-D1F9CE0FD6D7
P2860
Cyclophosphamide-sensitive T lymphocytes suppress the in vivo generation of antigen-specific cytotoxic T lymphocytes.
description
1977 nî lūn-bûn
@nan
1977年の論文
@ja
1977年論文
@yue
1977年論文
@zh-hant
1977年論文
@zh-hk
1977年論文
@zh-mo
1977年論文
@zh-tw
1977年论文
@wuu
1977年论文
@zh
1977年论文
@zh-cn
name
Cyclophosphamide-sensitive T l ...... cific cytotoxic T lymphocytes.
@en
type
label
Cyclophosphamide-sensitive T l ...... cific cytotoxic T lymphocytes.
@en
prefLabel
Cyclophosphamide-sensitive T l ...... cific cytotoxic T lymphocytes.
@en
P2093
P2860
P356
P1476
Cyclophosphamide-sensitive T l ...... cific cytotoxic T lymphocytes.
@en
P2093
Pfizenmaier K
Röllinghoff M
Starzinski-Powitz A
P2860
P304
P356
10.1084/JEM.145.2.455
P407
P577
1977-02-01T00:00:00Z